R1 Therapeutics expands Series A financing to $80.5 million with Samsara Biocapital
Reuters reports R1 Therapeutics expanded its Series A financing to $80.5 million, with investment from Samsara Biocapital.
Reuters reports R1 Therapeutics expanded its Series A financing to $80.5 million, with investment from Samsara Biocapital.